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Severe combined immunodeficiency (SCID) mice,
the most widely used animal model of DNA-PKcs
(Prkdc) deficiency, have contributed enormously to
our understanding of immunodeficiency, lymphocyte
development, andDNA-repairmechanisms, and they
are ideal hosts for allogeneic and xenogeneic tissue
transplantation. Here, we use zinc-finger nucleases
to generate rats that lack either the Prkdc gene
(SCID) or the Prkdc and Il2rg genes (referred to as
F344-scid gamma [FSG] rats). SCID rats show
several phenotypic differences from SCID mice,
including growth retardation, premature senes-
cence, and a more severe immunodeficiency without
‘‘leaky’’ phenotypes. Double-knockout FSG rats
show an even more immunocompromised pheno-
type, such as the abolishment of natural killer
cells. Finally, xenotransplantation of human induced
pluripotent stem cells, ovarian cancer cells, and
hepatocytes shows that SCID and FSG rats can act
as hosts for xenogeneic tissue grafts and stem cell
transplantation and may be useful for preclinical
testing of new drugs.
INTRODUCTION
DNA-dependent protein kinase catalytic subunits (DNA-PKcs)
are critical components of the nonhomologous end-joining
(NHEJ) pathway of the DNA double-strand break (DSB) repair
system. DSBs are usually generated by environmental influences
such as ionizing radiation (IR) or by chemical mutagens, or are
created during programmed processes such as V(D)J recombi-
nation or class switch recombination (CSR), which occur during
lymphocyte development (Franco et al., 2006; Mahaney et al.,
2009; Shrivastav et al., 2008; Yan et al., 2007). The Ku70/80 het-
erodimer first binds to the ends of the DSBs and recruits DNA-CelPKcs to form the active DNA-PK complex. Subsequently,
together with Artimis, DNA-PKcs stimulate the processing of
the DNA ends. Finally, the LIG4 complex, comprising LIG4,
XRCC4, and XLF, seals the DSBs generated during NHEJ.
Humans and several types of mammals with a defect in the
genes involved in NHEJ cannot complete V(D)J recombina-
tion. This blocks lymphocyte development, resulting in severe
combined immunodeficiency (SCID) (Bosma et al., 1983; O’Dris-
coll and Jeggo, 2006; Perryman, 2004; van der Burg et al., 2009).
SCID mice, which arose spontaneously due to the defective
DNA-PKcs gene (Prkdc), show an immunodeficient phenotype
and increased sensitivity to IR (Bosma et al., 1983). In contrast,
no PRKDC mutations had been reported in humans until
recently, when a hypomorphic mutation with PRKDC kinase
activity was identified in a patient with SCID with sensitivity to
IR (RS-SCID; van der Burg et al., 2009). Although complete
PRKDC deficiency is expected to be lethal in humans, sponta-
neous null mutations in the PRKDC gene were reported in
Arabian horses and Jack Russell terriers, highlighting the fact
that PRKDC deficiency is not tolerated equally in all species
(Perryman, 2004).
SCID animals are widely used in biomedical research as hosts
for allogeneic and xenogeneic tissue grafts. Humanized mice
(i.e., immunodeficient mice engrafted with human cells or
tissues, such as human hematopoietic stem cells [hHSCs],
hepatocytes, or tumor cells) are powerful tools that have enabled
scientists to gain greater insights into many human diseases
(Azuma et al., 2007; Baiocchi et al., 2010; Brehm et al., 2010;
Denton andGarcı´a, 2011; Ito et al., 2008; Katoh et al., 2008; Kne-
teman and Mercer, 2005; Leonard, 2001; Meuleman et al., 2005;
Pearson et al., 2008; Quintana et al., 2008; Shultz et al., 2007;
Wege et al., 2008). Although the laboratory rat is an ideal model
for physiological, pharmacological, toxicological, and trans-
plantation studies, there are no reports of spontaneous, or
gene-targeted, SCID rats. Recently, several strategies have
been developed to produce awide variety of genomic alterations
in rats (Geurts et al., 2009; Izsva´k et al., 2010; Mashimo et al.,
2008; Tesson et al., 2011), including embryonic-stem-cell-
derived p53 knockout rats (Tong et al., 2010). Other investigatorsl Reports 2, 685–694, September 27, 2012 ª2012 The Authors 685
Figure 1. Injection of ZFN-Encoding mRNA
into Rat Embryos Induces Targeted Loss-
of-Function Mutations
(A) Schematic representation of the part of rat
Prkdc gene. The magnified views illustrate the
binding sites for the ZFN pairs.
(B) Injection of ZFN-encoding mRNA into F344/
Stm or Crlj:WI rat fertilized oocytes.
(C) PCR analysis of 16 offspring obtained by ZFN
injection of F344/Stm oocytes. M, DNA molecular
weight marker 4X174-HaeIII digest.
(D) Sequencing assay for ZFN-induced mutations
in the target region in F344 rats. Multiple deletions
and insertions are depicted by red dashes and
letters, respectively, and are aligned along the WT
sequences shown on the top line.
(E) RT-PCR analysis of PrkdcmRNA expression in
the spleen of Prkdc (+/+, +/, /) rats. Gapdh
mRNA expression was used as an internal control.
(F) Western blot of PRKDC protein in the spleen of
Prkdc (+/+, +/, /) rats. b-actin was used as
a loading control.
See also Figures S1 and S4.and our group have also shown the successful application of
zinc-finger nucleases (ZFNs) as a gene-targeting technology in
rats, which is faster and more efficient than embryonic-stem-686 Cell Reports 2, 685–694, September 27, 2012 ª2012 The Authorscell-mediated knockout technology (Cui
et al., 2011; Geurts et al., 2009; Mashimo
et al., 2010).
Here, we report the generation
and characterization of single-knockout
Prkdc (SCID) and double-knockout Prkdc
and Il2rg (F344-scid gamma [FSG]) rats.
RESULTS
Generation of SCID Rats Using
ZFNs
The design and validation of ZFN
reagents targeting the first exon of rat
Prkdc gene were described previously
(Mashimo et al., 2010) (Figure 1A; Fig-
ure S1). The validated ZFN mRNA was
microinjected into fertilized F344/Stm or
Crlj:WI oocytes, which were then trans-
ferred into the oviducts of pseudopreg-
nant Crlj:WI female rats (Figure 1B).
Screening of 39 newborn animals re-
vealed that 26 of them (66.7%) carried
mutations, comprising deletions from
1 bp to 919 bp and a 1-bp insertion
(Figures 1C and 1D; Figure S2). The rate
and variation of the ZFN-induced muta-
tions were similar to those reported in
previous studies (Cui et al., 2011; Geurts
et al., 2009; Mashimo et al., 2010). The
majority of these were frame-shift muta-
tions resulting in the complete loss ofmRNA expression as confirmed by reverse transcriptase (RT)-
PCR (Figure 1E) and protein expression as confirmed by western
blotting (Figure 1F). Furthermore, double injection of Prkdc and
interleukin 2 receptor-gamma (Il2rg) ZFN-encoding mRNA into
219 fertilized F344/Stm oocytes resulted in one male carrying
7- and 46-bp deletions in Prkdc, and one female carrying 227-
and 716-bp deletions in Prkdc and a 3-bp deletion in Il2rg
(Figure 1B).
To clarify whether the ZFNs only induced mutations in the
targeted region, we checked 12 sites that showed a high rate
of similarity to the targeted site at the sequence level with no
more than 7–8 bp mismatches, as illustrated in Table S1. Inser-
tions or deletions were not observed at any of these off-target
sites among the ZFN-modified founders. Although we cannot
exclude the possibility that the ZFNs cleaved unknown off-target
sites, we subsequently excluded such undesired mutations
excluded from the genome of the carrier animals by backcross-
ing to the parental strain. After crossing with wild-type (WT)
animals, the ZFN-induced Prkdc and Il2rg mutations were faith-
fully transmitted through the germline. Some of the ZFN-modi-
fied founders were subsequently bred to homozygosity for use
in further experiments.
Growth Retardation in SCID Rats
Heterozygous Prkdc+/ rats were indistinguishable from their
WT littermates in all respects. Approximately 25% of the off-
spring born to Prkdc+/ 3 Prkdc+/ crosses were homozygous
Prkdc/ rats, and were significantly smaller than their WT and
heterozygous littermates (Figure 2A). When the embryos from
Prkdc+/3 Prkdc+/ crosses were examined and weighed, a dif-
ference in size was observed at embryonic day 14.5 (E14.5),
which became statistically significant at E17.5 (Figure 2B).
During the 6 month observation period, the Prkdc/ rats grew
and maintained a body weight that was 70% of that of the
controls (Figure 2C). Prkdc/ SCID rats normally survive for
at least 1 year under specific pathogen-free conditions. Both
male and female Prkdc/ rats were fertile, but the average litter
size was small (4.7 ± 2.0 [n = 9] versus 9.1 ± 1.6 of F344 rats
[n = 12]). Newly generated F344-Prkdc/ Il2rg/ rats (FSG
rats) showed phenotypes similar to those of SCID rats for
growth, survival, and reproducibility (Figure 2C).
To further characterize the growth deficiency, we derived
primary fibroblasts from WT (+/+), heterozygous (+/), and
homozygous (/) rat embryos (rat embryonic fibroblasts
[REFs]), and monitored their growth in vitro (Figure 2D).
Early-passage Prkdc/ REFs grew slowly, at a rate 70% of
that shown by the Prkdc+/ and Prkdc+/+ REFs. This difference
was partly due to a decrease in the number of dividing cells
within the Prkdc/ cultures, as determined by incorporating
bromodeoxyuridine (BrdU) into chromosomal DNA during an
18 hr labeling period (Figure 2E). Proliferation decreased with
passage number, and by passage 4, Prkdc/ REF cultures
contained nondividing giant cells, suggesting premature senes-
cence (Figure 2F). Senescence-associated b-galactosidase
(SA-b-Gal) activity assays showed significantly higher numbers
of SA-b-Gal-positive cells within Prkdc/ REF cultures com-
pared with Prkdc+/ or Prkdc+/+ REF cultures (Figure 2G). To
the best of our knowledge, neither growth retardation nor pre-
mature senescence has been reported in SCID mice (Bosma
et al., 1983; Gao et al., 1998; Jhappan et al., 1997; Taccioli
et al., 1998).CelIR Sensitivity and DSB-Repair Defects in SCID REFs
Mouse embryonic fibroblasts (MEFs) from SCID mice or Prkdc-
deficient mice, and the Prkdc-deficient human glioma cell line
M059J are all IR-sensitive, although the level of sensitivity varies.
Whenwe used a colony survival assay to test IR sensitivity in REF
cells, Prkdc/ REFs were significantly more sensitive than
Prkdc+/ or Prkdc+/+ REFs (Figure 2H). Accordingly, Prkdc/
REF cells accumulated foci comprising histone H2AX (gH2AX),
a surrogate marker for DSBs, after an exposure to 1 Gy of irradi-
ation (Figure 2I).
We next used a pEJ assay (Kobayashi et al., 2010) and
a DR-GFP (Pierce and Jasin, 2005) assay to further examine
the effects of Prkdc-deficiency on the NHEJ and homologous
recombination (HR) pathways, respectively. After the gen-
eration of DSBs using I-SecI, the number of GFP-positive
Prkdc/ REFs in the pEJ assay significantly decreased com-
pared with that of Prkdc+/+ REFs (Figure 2J), clearly indicating
a severe deficiency in the NHEJ pathway in these cells. In con-
trast, the HR pathway was significantly increased in Prkdc/
REFs (Figure 2K), suggesting that a deficiency in the NHEJ
pathway induces a more active HR pathway as a compensatory
mechanism.
Impaired Lymphoid Development in SCID Rats
Gross and microscopic analyses of SCID and FSG rats revealed
abnormal lymphoid development (Figures 3A–3D). The thy-
muses from SCID and FSG rats were extremely hypoplastic
(Figure 3A) and comprised an epithelial rudiment without any
lymphocytes (Figure 3C). The spleens were also smaller (Fig-
ure 3B), with severely hypoplastic white pulp, and red pulp con-
taining myeloid cells (Figure 3D). Serum immunoglobulin (Ig)
levels (IgA and IgM) were undetectable in 5-week-old Prkdc/
rats, whereas IgG levels in Prkdc/ rats nursed by Prkdc+/
heterozygous mothers were detected at half the levels seen in
control Prkdc+/+ rats (Figures 3E–3G), confirming the postnatal
transfer of maternal IgG previously described in rodents (Gus-
tafsson et al., 1994). IgG levels were lowest in 8-week-old
Prkdc/ rats, and undetectable in 5-week-old Prkdc/ rats
nursed by Prkdc/ homozygous mothers (Figure 3E). Approxi-
mately 20% of young adult (or of the majority of old SCID)
mice known to have a ‘‘leaky’’ phenotype showed detectable
Ig levels, generated by a few clones of functional B cells (Bosma
et al., 1983). To date, none of the SCID rats examined (n = 9, until
1 year of age) have shown a leaky phenotype for serum Ig
(Figures 3E–3G).
Consistent with the histology, the number of thymocytes and
splenocytes was markedly reduced in SCID and FSG rats
compared with control F344 rats (Table S2). In the peripheral
blood (PB) profile, the number of white blood cells (WBCs)
was reduced in SCID and FSG rats compared with F344 rats
(Table S3). Differential counts of WBCs showed a dramatic
decrease in leucocytes and relative increases in neutrophils
and monocytes in SCID and FSG rats (Table S4).
To further characterize the immunological deficiency in SCID
rats, we examined cell populations isolated from the thymus,
spleen, and bone marrow (BM) using flow cytometry (Figures
3H–3J). CD4+ or CD8+ single-positive (SP), and CD4+CD8+
double-positive (DP) T cells were completely absent from SCIDl Reports 2, 685–694, September 27, 2012 ª2012 The Authors 687
Figure 2. Prkdc Deficiency in Rats Results in Growth Retardation, Premature Senescence, and Radiation Sensitivity
(A) Photograph of newborn for Prkdc/, Prkdc+/, and WT Prkdc+/+ littermates.
(B) Development of Prkdc (+/+, n = 3; +/, n = 6; /, n = 3) embryos, as measured by weight at E14.5, E17.5, and E20.5.
(C) Postnatal growth of Prkdc (+/+, n = 4; +/, n = 8; /, n = 4) and Prkdc/ Il2rg/ FSG (n = 5) rats.
(D) Proliferation of primary fibroblasts from Prkdc (+/+, n = 3; +/, n = 3;/, n = 3) E14.5 rats. Second-passage REFs were plated in 60 mm dishes and counted
every 2 days.
(E) Division of REFs from Prkdc (+/+, n = 3; +/, n = 3;/, n = 3) rats. Incorporation of BrdU into chromosomal DNA wasmeasured after an 18 hr labeling period.
(F) Proliferation of REFs from Prkdc (+/+, n = 3; +/, n = 3; /, n = 3) rats at each passage.
(G) Cell staining for senescence-associated SA-b-galactosidase activity. The percentage of SA-b-galactosidase-positive cells in the REF (+/+, n = 3; +/,
n = 3; /, n = 3) cells was calculated from the average from three experiments.
(H) Radiation sensitivity of Prkdc (+/+, +/, /) REF cell lines. Cells were irradiated with the indicated dose of g-rays, and viability was analyzed using colony
formation assays.
(I) g-H2AX focus formation assay in Prkdc (+/+, /) REF cell lines after exposure to 1 Gy of g-rays. Cells were stained with anti-g-H2AX antibody as a marker
for DSBs.
(J and K) NHEJ activity and HR activity of Prkdc (+/+, /) REF cell lines. I-SceI expression plasmids were introduced into each REF cell line by electroporation.
After 2 days, GFP-positive cells induced through the NHEJ pathway (J) or the HR pathway (K) were analyzed by flow cytometry.
Error bars indicate the mean ± SEM; *p < 0.05 for each genotype by one-way analysis of variance (C–H) or Student’s t test (J and K). See also Figure S2.thymuses but were abundant in control thymuses (Figure 3H).
This was clearly different from SCID mice, in which DP T cells
are present in the thymus (Gao et al., 1998; Taccioli et al.,
1998). CD3CD45RA+ B cells were completely absent from688 Cell Reports 2, 685–694, September 27, 2012 ª2012 The AuthorSCID spleens and BM, whereas CD3CD161a+ natural killer
(NK) cells were present or even increased (Figures 3I and 3J).
NK cell numbers were mostly depleted in the BM and spleens
of 5-week-old FSG rats (Figures 3I and 3J).s
Figure 3. Abnormal Lymphoid Development
in Prkdc-Deficient SCID Rats
(A and B) Pictures of thymus (A) and spleen (B)
from F344, SCID, and FSG rats.
(C) Histological analysis of the thymus (340). The
thymuses of SCID and FSG rats were severely
hypoplastic and consisted of an epithelial cell
sheet.
(D) Histological analysis of the spleen (3100). In
the spleens of SCID and FSG rats, the white pulp
was virtually devoid of lymphocytes and the red
pulp was occupied by a variety of myeloid cells.
(E–G) ELISA for serum IgG (E), IgA (F), and IgM (G)
levels in Prkdc SCID (+/+, n = 3; +/, n = 6; /,
n = 4) rats. Error bars indicate the mean ± SEM.
IgG, IgA, and IgM levels were very low or unde-
tectable in 5-week-old Prkdc/ rats nursed by
Prkdc/ homozygous mothers (M: /, n = 3),
whereas IgGwas detected in 5-week-oldPrkdc/
rats nursed by a Prkdc+/ heterozygous mother
(M: +/, n = 4) at half the levels seen in the control
rats, probably due to transfer through the maternal
milk. IgG, IgA, and IgM levels were undetectable in
8-week-old FSG rats (n = 4) and 6-month-old
Prkdc/ rats (+/+, n = 6; /, n = 5).
(H–J) Flow cytometric analysis of cell populations
isolated from thymus (H), spleen (I), and BM (J) in
SCID and FSG rats. Dot plots represent CD3, CD4,
and CD8 cells for demarcation of T cell sub-
populations, and CD3, CD45RA, and CD161a
cells for differentiation of T cell, B cell, and NK
cell subpopulations. CD4+ and CD8+ SP, and
CD4+CD8+ DP T cells were absent from SCID
thymuses (H). CD3CD45RA+ B cells were absent
from the spleens (I) and BM (J) of SCID and FSG
rats. CD3CD161a+ NK cells were present in
the SCID, but were mostly diminished in FSG rats
(I and J).Xenotransplantation of Human Induced Pluripotent
Stem Cells and Tumor Cells
SCID mice can accept transplanted tissues from other species,
including humans. We used SCID rats in a teratoma formationCell Reports 2, 685–694, Seassay. Teratomaswere induced by inocu-
lation of human induced pluripotent stem
(iPS) cells beneath the testis capsule (Ta-
kahashi et al., 2007). All SCID (n = 4/4) and
FSG (n = 3/3) rats developed tumors, and
in most cases, both testes were affected
(Figure 4A). Histological examination
showed that the lesion had displaced
the normal testis and contained solid
areas of teratoma. All teratomas con-
tained differentiated tissues representing
all three germ layers, including columnar
epithelium, pseudostratified ciliated epi-
thelium (endoderm), neural rosettes (ec-
toderm), cartilage, and adipose tissue
(mesoderm; Figures 4B–4F).
To further evaluate the immunological
defects, we used SCID and FSG rats ashosts for the xenotransplantation of human ovarian cancer
cells (Mashimo et al., 2010). All SCID rats (n = 6/6) developed
tumors within 14 days after injection of ovarian cancer cells,
whereas control F344 rats showed no evidence of tumor growthptember 27, 2012 ª2012 The Authors 689
Figure 4. Xenotransplantation of Human
iPS Cells, Tumor Cells, and Hepatocytes
into SCID and FSG Rats
(A) Teratoma formation assay for human 201B7
iPS cells in the testis of SCID and FSG rats.
(B–F) Histology of differentiated elements found in
teratomas: (B) columnar epithelium (endoderm),
(C) pseudostratified ciliated epithelium, (D) neural
rosettes (ectoderm), (E) cartilage (mesoderm), and
(F) adipose tissue.
(G) Subcutaneous injection of human A2780
ovarian cancer cells into F344 (n = 6), SCID (n = 6),
and FSG (n = 6) rats.
(H) Growth curve of human ovarian cancer cells.
SCID rats developed tumors within 14 days after
injection, whereas FSG rats showed more rapid
cell proliferation, probably due to the lack of NK
cells.
(I–M) Human hepatocytes were transplanted into
retrorsine-treated infant FSG (n = 4) and control
F344 (n = 3) rats. hAlb was detected in the blood of
all transplanted FSG rats (I). The detection limit for
hAlb (156.3 ng/ml) is indicated by the dotted line.
Error bars indicate the mean ± SEM (H and J).
*p < 0.05 for SCID versus FSG (H) and for F344
versus FSG (I) by Student’s t test.
(J and K) Liver sections stained with human cyto-
keratin 8/18 (hCK8/18) show engraftment and
repopulation of donor human hepatocytes in the
recipient rat livers. The sections were counter-
stained with hematoxylin. The region enclosed by
the square in (J) is magnified in (K).
(L) Colonies of cells with a clear cytoplasm were observed in liver sections stained with H&E. The cells were uniform in size, and most were mononuclear.
(M) Proliferated human hepatocytes were labeled with BrdU as shown by arrows. The sections were counterstained with H&E.
Bars = 100 mm (J–M). See also Figure S3.(n = 0/6; Figure 4G). Of interest, human cancer cells proliferated
more rapidly in FSG rats (n = 6/6), presumably due to the lack of
NK cell activity in these animals (Figure 4H). The tumors were
confirmed by histological analysis, and by PCR using primers
to amplify the humanMHC class II DQB2 region. These observa-
tions illustrate the impaired immune system of SCID and FSG
rats, and clearly show that these animals will be useful models
for cancer and stem cell research.
Transplantation of Human Hepatocytes and hHSCs
The different metabolic enzyme profiles in human and rat livers
are a major limitation for toxicology and drug testing. We gener-
ated liver-humanized rats by injecting human hepatocytes into
the livers of infant FSG rats pretreated with a pyrrolizidine alka-
loid (retrorsine) that is toxic to hepatocytes (Figures 4I–4M). In
this study we used FSG rats because they have more immuno-
compromised states compared with SCID rats, as observed in
the tumor cell engraftment. Human albumin (hAlb) was detect-
able in the blood of all FSG rats (>1 3 103 ng/ml, n = 3) 1 week
after transplantation (Figure 4I). The hAlb levels increased until
6 weeks after transplantation. However, hAlb was not detectable
in F344 control rats (n = 4). Small clusters of human cytokeratin
8/18 (hCK8/18)-positive cells were observed in the livers of the
transplanted FSG rats, indicating the successful engraftment
and repopulation of human hepatocytes at the tissue level
(Figures 4J and 4K). The human hepatocytes within these colo-690 Cell Reports 2, 685–694, September 27, 2012 ª2012 The Authornies were morphologically normal but their cytoplasm appeared
to be clear (Figure 4L), probably because of the high glycogen
content previously reported in liver-humanized mice (Tateno
et al., 2004). The BrdU-positive donor cells within the colonies
represented the proliferation of engrafted human hepatocytes
in the livers of FSG rats (Figure 4M).
The engraftment of hHSCs in immunodeficient mice, such as
SCID-hu models (Brehm et al., 2010; Denton and Garcı´a, 2011;
McCune et al., 1989; Pearson et al., 2008; Shultz et al., 2007;
Wege et al., 2008), provides an opportunity to study the human
immune system in vivo. To test the capability of this feature,
we injected human cord blood (hCB) CD34+ cells into 4-week-
old FSG rats. During the 3-month monitoring period after trans-
plantation, no human CD45+ cells could be detected in the PB of
hHSC-transplanted FSG rats (Figure S3A). Neither human CD3+
T cells nor CD19+ B cells were detected in the PB, spleen, or BM
(Figure S3B). Furthermore, 6 months after transplantation, no
human CD45+ cells were detected in FSG rats (Figure S3C).
DISCUSSION
In this study, we successfully generated Prkdc-deficient SCID
rats by using the ZFN technology. The SCID rats were signifi-
cantly different from SCID mice, in that they showed growth
retardation, defects in fibroblast proliferation, and a more severe
immunodeficient phenotype. This suggests that DNA-PKcs haves
distinct functions in mice and rats. Although few studies have
examined spontaneous null mutations in human DNA-PKcs, it
has been reported that gene-targeting disruption of human
somatic cells results in profound growth retardation, IR sensi-
tivity, and increased genetic instability (Ruis et al., 2008). The
most reasonable explanation for the phenotypic differences
between mice and humans is that human cells express 50 times
more DNA-PK activity than rodent cells (Finnie et al., 1995). Our
expression analysis of spleen and fibroblast cells showed that
humans express many more DNA-PKcs compared with rodents,
and rats express three times more compared with mice (Fig-
ure S2). Although DNA-PKcs play a major role in DSB repair
(as do other members of the phosphatidylinositol 3-kinase-
related kinase [PIKK] family, including ATM and ATR), their exact
role is still not completely understood. There are at least three
DSB repair pathways: NHEJ, HR, and the alternative NHEJ
pathway (Mahaney et al., 2009; Shrivastav et al., 2008; Zha
et al., 2011). The pathway used for DSB repair seems to differ
between species. NHEJ, in which DNA-PKcs play a key role, is
considered to be an error-prone pathway, whereas HR (the
major process in lower eukaryotes that lack a DNA-PKcs
enzyme) is error-free. Considering that much of the genome in
higher eukaryotes comprises less-well-conserved noncoding
DNA, NHEJ may have evolved along with DNA-PK activity,
particularly in higher mammalian species.
Although SCID mice are the most commonly used experi-
mental animal model for xenograft transplantation, the normal
NK cell activity observed in these animals contributes to the
limited longevity and function of transplanted human cells (Shultz
et al., 2007). Therefore, we additionally generated FSG rats,
which show no such NK cell activity. Although both SCID and
FSG rats could serve as hosts for xenogeneic cell grafts such
as human iPS cells and ovarian cancer cells, the FSG rats
showed higher proliferation of human tumor cells than the
SCID rats (Figure 4H), indicating a more severely immunocom-
promised state similar to that reported in Prkdc- and Il2rg-defi-
cient mice used for xenotransplantation of human melanoma
cells (Quintana et al., 2008) or human blood cells (Ishikawa
et al., 2005). Further transplantation studies using diverse human
cancer cells, such as preclinical cancer cells or cancer stem
cells, will be interesting and will improve our understanding of
severely immunocompromised hosts.
In addition, we engrafted human hepatocytes into the livers
of retrorsine-treated FSG rats (Figure 4I–4M). hAlb was secreted
in the blood of transplanted FSG rats, and clusters of human
transplanted hepatocytes were observed in the livers of the
FSG rats. Liver-humanized rats have several advantages over
mouse models: (1) rats are 10 times larger than mice, providing
greater blood volumes and more bile acid, cells, and tissues;
(2) pharmacological and toxicological data have been accumu-
lated for rats; and (3) it is easier to perform complex surgical
experiments in rats. Liver-humanized rats may also allow
large-scale and high-quality proliferation of either WT human
hepatocytes or iPS-derived hepatocytes, which is currently a
considerable obstacle to the culture of human hepatocytes.
Liver-humanized rats would provide a robust platform for in vivo
toxicological assays and drug metabolism assays. Although the
replacement rate of human hepatocytes in the FSG rats was stillCellower compared than that previously obtained in liver-human-
ized mice (Azuma et al., 2007; Strom et al., 2010; Tateno et al.,
2004) that were genetically modified using either uroplasmino-
gen activator (uPA) transgenes (Tateno et al., 2004) or Fumaryl
acetoacetate hydrolase (Fah) knockouts (Strom et al., 2010),
similar genetic alterations in rats will probably also improve the
engraftment success in liver-humanized rats.
Despite these successful results for transplantation of
human iPS cells, tumor cells, and hepatocytes, the FSG rats
rejected transplanted hHSCs (Figure S3). In mice, xenotrans-
plantation in the nonobese diabetic Prkdcscid (NOD.SCID) or
NOD.Prkdcscid.Il2rg/ (NSG or NOG) mouse has become the
gold-standard assay for hHSCs, highlighting the importance of
the genetic background for such transplantation experiments.
Recently, it was shown that the signal regulatory protein alpha
(Sirpa) of the NOD allele enhances binding to the human CD47
and could provide inhibitory regulation of mouse phagocytes
by CD47-SIRPa interaction (the so-called ‘‘don’t eat me’’ signal),
allowing significantly increased engraftment andmaintenance of
hHSCs in the mouse BM (Takenaka et al., 2007). This was also
supported by experiments in which transgenic mice with human
SIRPa in the non-NOD background showed significantly higher
levels of human cell engraftment comparable to those in NSG
mice (Strowig et al., 2011). Transgenic FSG rats with human
SIRPa or NOD-SIRPa may change the BM microenvironment
of FSG rats in a way that allows them to accept the engraftment
of hHSCs. In addition to Sirpa, structural species-specific differ-
ences in the BM environment between mice and rats, and differ-
ences in the protocols used for HSC engraftment may explain
why transplantation of hHSCs fails in FSG rats.
In conclusion, the newly developed SCID and FSG rats
described in this study can be a valuable resource in various
fields, such as stem cell research and translational research,
and serve as an important experimental model for preclinical
drug testing. These humanized models will also allow preclinical
evaluation of stem-cell-based therapies and expand the options
for translational research. This is particularly important in the field
of regenerative medicine, because humanized rats can be used
to evaluate not only the ability of the cells to engraft but also their
therapeutic efficiency. However, additional genetic modifica-
tions may be required to permit transplantation of human cells
or tissues, such as human hepatocytes and hHSCs.
EXPERIMENTAL PROCEDURES
Generation of Knockout Rats Using ZFNs
Custom-designed ZFN plasmids for the rat Prkdc gene and the Il2rg genewere
obtained from Sigma-Aldrich (St. Louis, MO). The design, cloning, and valida-
tion of the ZFNs were performed as previously described (Mashimo et al.,
2010). In brief, ZFNs were designed to recognize a site-specific sequence
within the first exon of the rat Prkdc gene (Figure S4). Approximately 2–3 pl
of ZFN mRNA (10 ng/ml) were injected into the pronuclei of embryos collected
from F344/Stm or Crlj:WI females as previously described (Mashimo et al.,
2010). The cultured embryos were then transferred to the oviducts of pseudo-
pregnant females (Crlj:WI, 8–10 weeks). To edit the ZFN cleavage site in the
genome at the Prkdc locus, two primer sets were designed to amplify small
(309 bp) and large (1,321 bp) fragments as shown in Figure S4. The PCR
products were directly sequenced using the BigDye terminator v3.1 cycle
sequencing mix and the standard protocol for an Applied Biosystems 3130
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All animal care and experiments conformed to the Guidelines for Animal
Experiments of Kyoto University, and were approved by the Animal Research
Committee of Kyoto University. Transplantation studies using human hepato-
cytes were approved by the Ethics Board of PhoenixBio Co., Ltd. (Higashihir-
oshima, Japan). All SCID rats were maintained under specific pathogen-free
conditions. The SCID rats are deposited in the National BioResource
Project–Rat in Japan (http://www.anim.med.kyoto-u.ac.jp/nbr).
RT-PCR and Western Blotting
Total RNA was extracted from the spleens of 5-week-old rats using Isogen
reagent (Nippon Gene, Tokyo, Japan). RT-PCR was performed using the
primers for Prkdc described in Figure S2, and with Gapdh 50-GGCACAGT
CAAGGCTGAGAATG-30 and 50-ATGGTGGTGAAGACGCCAGTA-30. Western
blotting was carried out using cell lysates from the spleens of 5-week-old
rats according to standard methods. Signals were detected with antibodies
against rat PRKDC (H-163; Santa Cruz Biotechnology, Santa Cruz, CA) and
b-actin (AC-40; Sigma Aldrich).
REF Culture, Proliferation Assays, and SA-b-Galactosidase Assay
REFs were isolated from embryos after 14.5 days of gestation from the female
partners of intercrossed Prkdc+/ rats. To obtain a growth curve, passage 2
REFs (23 104) were plated on six-well plates in triplicate. The cells were trypsi-
nized, stained with trypan blue, and counted every other day for a total of
8 days. For the BrdU incorporation assay, cells were plated with BrdU
(100 mM) and labeled for 48 hr in 96-well plates. The cells were stained with
the anti-BrdU-POD antibody and quantified by measuring the absorbance
with an enzyme-linked immunosorbent assay (ELISA) reader (BrdU Labeling
and Detection Kit III; Roche Applied Science, Indianapolis, IN). To assess
SA-b-galactosidase activity, cells were plated 60 mm dishes and stained for
24 hr. The percentage of SA-b-galactosidase-positive cells was determined
by manually counting the number of blue cells (Senescence Detection Kit;
BioVision, Mountain View, CA) within the total cell population.
Preparation of Immortalized REF Cells
Generation of immortalized REF cells by human telomerase reverse transcrip-
tase (hTERT) was performed as previously described (Nakamura et al., 2002).
Briefly, rat primary fibroblasts (+/+, +/, or /) were infected with an hTERT-
introduced retrovirus and then continuously cultured with G418. After a few
weeks, viable cells were infected with SV40 and then continuously cultured
for >1 month. These transformed cells (REF-hTERT/SV) were used for radia-
tion sensitivity assays, and HR and NHEJ assays.
Radiation Sensitivity Assay and Immunofluorescence Staining for g-
H2AX Foci
For the radiation sensitivity assays, the cells were trypsinized and irradiated
with 3 or 5 Gy of 60Co g-rays at a dose rate of 1.1 Gy/min. Immediately after
irradiation, the cells were plated into 100 mm dishes at a density such that
50–200 cells would survive, and then incubated for 10 days. The dishes
were then fixed with ethanol and stained with 3% Giemsa, and the number
of colonies was counted. The surviving fractions were calculated by com-
paring the number of colonies formed by irradiated cells with the number of
colonies formed by nonirradiated control cells. Each result represents an
average value from three independent experiments.
Immunostaining for g-H2AX foci was performed as previously described
(Kobayashi et al., 2010). Cells grown on a glass slide were fixed with cold
methanol for 15min, rinsedwith cold acetone several times, and then air-dried.
Anti-g-H2AX antibody (Upstate: #05-636) and Alexa-596-conjugated anti-
mouse IgG antibodies (Molecular Probes, Carlsbad, CA) were to visualize
the g-H2AX foci.
NHEJ and HR Assays
NHEJ and HR assays were performed as previously described (Kobayashi
et al., 2010; Pierce and Jasin, 2005). The cells were generated from REF-
hTERT/SV cells via introduction of a pEJ construct for the NHEJ assay or
a DR-GFP construct for the HR assay. To measure the repair of I-SceI-gener-
ated DSBs, 50 mg of the I-SceI expression vector (pCBASce) was introduced
into 1 3 106 cells by electroporation (GenePulser; Bio-Rad, Hercules, CA).692 Cell Reports 2, 685–694, September 27, 2012 ª2012 The AuthorTo determine the level of NHEJ or HR repair, the percentage of GFP-positive
cells was quantified by flow cytometry (FACSCalibur; Becton Dickinson,
Franklin Lakes, NJ) 3 days after electroporation.
Immunofluorescence and Fluorescence-Activated Cell-Sorting
Analysis
PB specimens were collected from the caudal vena cava. Serum Ig levels were
measured by ELISA using Rat IgG, IgA, and IgM ELISA quantitation kits (Bethyl
Laboratories, Montgomery, TX). For histopathology, tissues were fixed in
Bouin’s fluid and embedded in paraffin. The embedded tissues were then
sectioned (5–7 mm thick) at room temperature and stained with hematoxylin
and eosin (H&E) to permit evaluation by light microscopy.
Flow cytometric analysis of cell populations isolated from thymus, BM, and
spleen were carried out using IOTest Anti-Rat CD3-FITC/CD45RA-PC7/
CD161a-APC (Beckman Coulter, Fullerton, CA) to differentiate the T cell, B
cell, and NK cell subpopulations, and IOTest Anti-Rat CD3-FITC/CD4-PC7/
CD8-APC (Beckman Coulter) to enumerate the T cell subpopulations. Anti-
CD45monoclonal antibodies (Beckman Coulter) were used for the intracellular
staining of lymphocytes. Mouse IgM, IgG1, and IgG2a antibodies (Beckman
Coulter) were used as isotype-matched controls. The cell samples were
treated with FcR-blocking reagent (Miltenyi Biotec, Auburn, CA) for 10 min,
stained with the fluorochrome-conjugated antibodies for 30 min, and washed
three times with PBS/10% FCS. Stained cell samples were analyzed with the
use of a four-color fluorescence-activated cell-sorting (FACS) flow cytometer
(FACSCalibur; Becton Dickinson) and the data were analyzed with CellQuest
software (Becton Dickinson).
Teratoma Formation by Human iPS Cells
Human iPS cells (201B7) were supplied by the Center for iPS Cell Research
and Application, Kyoto University (Kyoto, Japan). Clumps of 2 3 105 human
iPS cells with an undifferentiated morphology were harvested at the time of
routine passage as described previously (Takahashi et al., 2007), and injected
into the testis of 6- to 8-week-old rats. Six to 8 weeks later, when testicular
lesions developed and were palpable, the resulting tumors were dissected,
fixed in 10% neutral buffered formalin, embedded in paraffin, and examined
histologically after H&E staining.
Tumor Cell Xenotransplantation
The human ovarian cancer cell line A2780 was purchased from the European
Collection of Cell Cultures (ECACC,Wiltshire, UK). Cells were cultured in RPMI
1640 medium (GIBCO, Fort Worth, TX) with 10% heat-inactivated FBS
(Hyclone, Logan, UT). Subcutaneous injections of 2 3 105 A2780 cells plus
Matrigel (Becton Dickinson) were performed on 5-week-old female rats.
Tumors were measured (length [a] and width [b]) in millimeters using calipers,
and tumor volumes (V) were calculated using the formula V = ab2/2, where a is
the longer of the two measurements. Human-specific PCR primers were
designed to amplify major histocompatibility complex class II DQ beta 2
(HLA-DQB2) at exon 4 as follows: 50-CCTAGGGTGGTCAGACTGGA-30 and
50-AAAATCCCCCAAAACAAAGG-30.
Transplantation of Human Hepatocytes
Human hepatocytes were isolated from human-hepatocyte chimeric mice
(PXB mice, http://www.phoenixbio.co.jp) using the two-step collagenase
perfusion method as described previously (Yamasaki et al., 2010). The donor
cells (cryopreserved human hepatocytes derived from a 5-year-old boy) were
purchased from BD Gentest (Becton Dickinson). Two-week-old rats were
given intraperitoneal injections of retrorsine (Sigma-Aldrich) at 10 mg/kg
body weight. Seven days after retrorsine treatment, the isolated human hepa-
tocytes (5 or 10 3 105 viable cells) were transplanted into the animals via the
portal vein. To deplete Kupffer cells, the rats were injected intraperitoneally
with 10 ml/kg of liposome-encapsulated clodronate 2 days before and
3 days after transplantation. Plasma samples were collected weekly and
hAlb levels were measured by ELISA (Human Serum Albumin ELISA Quantita-
tion Kit; Bethyl Laboratories). The rat livers were harvested 6 weeks after
transplantation. When necessary, BrdU (50 mg/kg; Sigma-Aldrich) was in-
jected intraperitoneally 1 hr before sacrifice. Paraffin and frozen sections
(5 mm thick) were prepared from the liver tissues and subjected to H&E ors
immunohistochemical staining using human-specific hCK8/18 mouse mono-
clonal antibodies (NCL5D3; MP Biomedicals, Aurora, OH) or BrdU mouse
monoclonal antibodies (Bu20a; Dako Cytomation, Glostrup, Denmark). The
antibodies were visualized with a Vectastain ABC Kit (Vector Laboratories,
Burlingame, CA) using DAB substrates.SUPPLEMENTAL INFORMATION
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